Alternatively, NIS mRNA levels quantified by an qRT-PCR array may be better equipped to distinguish between NIS-positive and NIS-negative breast tumors for gene expression profiling, however, qRT-PCR arrays capable of detecting genome wide expression are not yet commercially available. The gene discussed is SLC5A5; the disease is breast neoplasm.